PAA 5.26% 18.0¢ pharmaust limited

Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-10

  1. 210 Posts.
    lightbulb Created with Sketch. 126
    Just leaving this here for the uninitiated:
    https://hotcopper.com.au/data/attachments/5782/5782668-6327fd78f835bd4c891d15e890dba2ef.jpg


    This is how the patients who's time on MPL we know (from the NFL interim data release 22/08) look using the 10.6 month average (leaving the 13 months out as we don't know which patients are which):
    First dose of MPL after diagnosis (days):Duration of treatment
    (Average: 10.6 months x 30.4 days which is the average days in a month)
    Total time since diagnosis: Years since diagnosis
    1A3773226991.92
    2B3233226451.77
    3C4803228022.20
    4D6683229902.71
    5E4323227542.07

    The 13 month patients are even more impressive.

    Obviously the above is just a small snapshot until the full data is released, but the fact that all patients are still not only alive, but still breathing and swallowing unassisted is fantastic news for everyone involved.

    That top-line data can't come fast enough.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
-0.010(5.26%)
Mkt cap ! $71.26M
Open High Low Value Volume
19.0¢ 19.5¢ 18.0¢ $184.0K 982.2K

Buyers (Bids)

No. Vol. Price($)
8 176820 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 167405 5
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
-0.010 ( 5.26 %)
Open High Low Volume
19.5¢ 19.5¢ 18.0¢ 438529
Last updated 15.59pm 15/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.